Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 12:17 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 385–408 of 22,004 matching trials from the live ClinicalTrials.gov search.

Filters: Recruiting Clear all

Conditions: Microscopic Colitis
Interventions: Rifaximin 550mg; Drug
Lead sponsor: Eugene F Yen, MD; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Acute Myeloid Leukemia
Interventions: Venetoclax, Gemtuzumab, Ziftomenib; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 3 Years to 21 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Univentricular Heart, Congenital Heart Disease, Heart Failure NYHA Class III, Heart Failure NYHA Class IV
Interventions: iPSC-CL; Biological
Lead sponsor: HeartWorks, Inc.; Other
Eligibility: 18 Years to 40 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Epilepsy, Functional Neurological Disorder, Mild Cognitive Impairment, Dementia, Parkinson Disease, Concussion, Brain, Brain Tumor, Healthy
Interventions: Acute Exercise; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Post-Treatment Lyme Disease
Interventions: Transcranial Direct Current Stimulation (tDCS), Cognitive training; Device · Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: San Francisco, California • New York, New York

Conditions: Maternal Behavior, Postpartum Mood Disturbance
Interventions: The PEN-3 Intervention Model; Behavioral
Lead sponsor: Jackson State University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 2
States / cities: Jackson, Mississippi

Conditions: Bladder Cancer, Urinary Bladder Neoplasm, Urologic Neoplasms, Neoplasms, Urinary Bladder Diseases
Interventions: Fiducial marker placement, Multiparametric MRI (mpMRI); Procedure · Diagnostic Test
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 3
States / cities: Los Angeles, California • Boston, Massachusetts

Conditions: Heart Transplant, Pediatric Heart Transplant, Rejection, Cardiac MRI, Cell Free DNA
Interventions: Not listed
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 6 Years to 25 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 22
States / cities: Little Rock, Arkansas • Los Angeles, California • Palo Alto, California + 16 more

Conditions: Heart Failure, Congestive
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1988 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Labral Tear, Glenoid, Femoral Acetabular Impingement
Interventions: Blood Flow Restriction Rehabilitative Therapy, Sham BFR Rehabilitative Therapy; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 40 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Acute Lymphocytic Leukemia (ALL)
Interventions: Obecabtagene autoleucel; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Idiopathic Pulmonary Fibrosis
Interventions: Ifetroban Sodium, Placebo; Drug
Lead sponsor: Cumberland Pharmaceuticals; Industry
Eligibility: 40 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 20
States / cities: La Mesa, California • San Francisco, California • Farmington, Connecticut + 17 more

Conditions: Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Interventions: ILKN421H, Pembrolizumab; Drug
Lead sponsor: iLeukon Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Los Angeles, California • Fort Worth, Texas

Conditions: Childhood Obesity
Interventions: Intensive Behavioral Lifestyle Modification; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 5 Years to 17 Years
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Baton Rouge, Louisiana • Nashville, Tennessee

Conditions: Anxiety, Anesthesia Awareness
Interventions: Survey using a questionnaire.; Other
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Intubation Complication
Interventions: Smart Checklist; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: Up to 19 Years
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 6
States / cities: Little Rock, Arkansas • Atlanta, Georgia • Omaha, Nebraska + 3 more

Conditions: Opioid Use Disorder
Interventions: Psilocybin; Drug
Lead sponsor: Anna Rose Childress, Ph.D.; Other
Eligibility: 18 Years to 60 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Advanced Solid Tumor
Interventions: AMT-116; Drug
Lead sponsor: Multitude Therapeutics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Denver, Colorado • Dallas, Texas

Conditions: Chronic Obstructive Pulmonary Disease (COPD), Allergies
Interventions: Omalizumab (Xolair®), Sodium Chloride (NaCl) 0.9 %; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 40 Years and older
Enrollment: 334 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 23
States / cities: Birmingham, Alabama • Tucson, Arizona • San Francisco, California + 16 more

Conditions: Lung Transplant, Well-Being, Psychological
Interventions: Latin Dance; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: IBD, Crohn Disease (CD), Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD), Ultra Processed Food, Nutrition Assessment, DGBI
Interventions: Handout-Only Intervention, Handout + Video Intervention; Behavioral
Lead sponsor: Connecticut Children's Medical Center; Other
Eligibility: 10 Years to 21 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Locally Advanced/Metastatic Solid Tumors
Interventions: ISM3412; Drug
Lead sponsor: InSilico Medicine Hong Kong Limited; Industry
Eligibility: 18 Years and older
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 5
States / cities: Denver, Colorado • New Haven, Connecticut • Indianapolis, Indiana + 2 more

Conditions: Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Neuroendocrine Tumor (NET)
Interventions: Structured Lipid Medical Food; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Pediatric Cancer, Oncology, Disruptive Behavior
Interventions: Internet-Based Parent-Child Interaction Therapy; Behavioral
Lead sponsor: Johns Hopkins All Children's Hospital; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: St. Petersburg, Florida

Search by objective public record fields.

Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis

A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia

Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease

EXercise-induced PhysioLogical Adaptations In Neurological Disorders

Transcranial Direct Current Stimulation for Post Treatment Lyme Disease

Mississippi Delta Community Care Home Visits Program

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

Non-invasive Prediction of EArly Cardiac rEjection

Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism

Blood Flow Restriction Following Hip Arthroscopy

Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer

The Dose Trial: Dose Intensity of Behavioral Interventions for Childhood Obesity

Fear and Anxiety in Anesthesia-Naïve Patients Pre-operatively vs Post-operatively

Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study

Wellcome Leap Psilocybin for OUD

AMT-116 in Patients With Advanced Solid Tumors

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

A Study of Latin Dance for Post- Lung Transplant

Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD

Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors

Nutrition Intervention for Pancreatic Cancer

Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer